Particularities of quality and safety control in cancer care (literature review)

Cover Page

Cite item

Full Text

Abstract

Introduction. Last decade significant progress was made in the development of cancer care algorithms. In this regard, new challenges are constantly being presented to the quality control of medical activities in actual practice.

Aims. To summarize the outlines regarding the most relevant criteria for assessing the quality in oncology.

Material and methods. The PubMed database (Medline) was used to identify the relevant and reliable sources of literature. The thematic methodology for obtaining information was used. 

Results. In total, over 80 most significant publications were identified, thoroughly studied and analyzed. International experience indicates the advantages for assessing the quality of cancer care by determining and measuring certain indicators. The model for quality assessment proposed by Donabedian A. (1966) is broadly applied in current medical practice. This model distinguishes the following: 1) structural indicators, 2) process indicators, 3) outcome indicators. Feedback is critically important in the organization of the audit of medical activities. It allows one to adapt the assessment methods by focusing on the tasks immediately during the control process. Because of cancer heterogeneity, there are apart requirements for developing quality indicators for each specific type of cancer because of cancer heterogeneity. 

Conclusions. Monitoring of medical activities is a crucial pillar for a robust healthcare system. The introduction of essential, practical and specialized audit techniques helps to improve the quality and safety of medical technologies used in cancer care. There is an increasing need to develop optimal indicators and standard operating procedures for the control of cancer care.

About the authors

Dmitriy A. Andreev

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

Author for correspondence.
Email: andreevda@zdrav.mos.ru
ORCID iD: 0000-0003-0745-9474

МD, PhD, Leading Researcher, Scientific and Clinical Department, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department, Moscow, 115088, Russian Federation.

e-mail: andreevda@zdrav.mos.ru

Russian Federation

Alexandr A. Zavyalov

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

Email: noemail@neicon.ru
ORCID iD: 0000-0003-1825-1871
Russian Federation

References

  1. Cheung P.S. Recent advances in breast cancer treatment. Hong Kong Med. J. 2018; 24(1): 6-8. https://doi.org/10.12809/hkmj175077
  2. Markham M.J., Wachter K., Agarwal N., Bertagnolli M.M., Chang S.M., Dale W., et al. Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J. Clin. Oncol. 2020; 38(10): 1081. https://doi.org/10.1200/JCO.19.03141
  3. Pucci C., Martinelli C., Ciofani G. Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience. 2019; 13: 961. https://doi.org/10.3332/ecancer.2019.961
  4. Poskus E., Kryzauskas M., Poskus T., Mikalauskas S., Samalavicius N.E., Aliosin O., et al. Improved perioperative care is associated with improved long-term survival in colorectal cancer. Int. J. Colorectal Dis. 2018; 33(6): 779-85. https://doi.org/10.1007/s00384-018-3021-y
  5. Haslem D.S., Van Norman S.B., Fulde G., Knighton A.J., Belnap T., Butler A.M., et al. A Retrospective analysis of precision medicine outcomes in patients with advanced cancer reveals improved progression-free survival without increased health care costs. J. Oncol. Pract. 2017; 13(2): e108-19. https://doi.org/10.1200/JOP.2016.011486
  6. Moy B., Polite B.N., Halpern M.T., Stranne S.K., Winer E.P., Wollins D.S., et al. American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J. Clin. Oncol. 2011; 29(28): 3816-24. https://doi.org/10.1200/JCO.2011.35.8903
  7. Hanson L.C., Collichio F., Bernard S.A., Wood W.A., Milowsky M., Burgess E., et al. Integrating palliative and oncology care for patients with advanced cancer: a quality improvement intervention. J. Palliat. Med. 2017; 20(12): 1366-71. https://doi.org/10.1089/jpm.2017.0100
  8. James T.A., Wong S.L., Carp N.Z. Measuring quality in cancer care: A critical need for clinician engagement. Am. J. Med. Qual. 2016; 31(5): 389-91. https://doi.org/10.1177/1062860616639639
  9. Qenam B.A., Li T., Tapia K., Brennan P.C. The roles of clinical audit and test sets in promoting the quality of breast screening: a scoping review. Clin. Radiol. 2020; 75(10): 794.e1-794.e6. https://doi.org/10.1016/j.crad.2020.01.015
  10. Edge S.B. Quality measurement in breast cancer. J. Surg. Oncol. 2014; 110(5): 509-17. https://doi.org/10.1002/jso.23760
  11. Rossi C.R., Sommariva A., Bastiaannet E., Van De Velde C.J.H. Quality assurance and sustainability of cancer care: A European network is needed. Eur. J. Surg. Oncol. 2018; 44(4): 383-5. https://doi.org/10.1016/j.ejso.2017.12.009
  12. Torras M.G., Canals E., Munoz-Montplet C., Vidal A., Jurado D., Eraso A., et al. Improving quality of care and clinical outcomes for rectal cancer through clinical audits in a multicentre cancer care organisation. Radiat. Oncol. 2020; 15(1): 28. https://doi.org/10.1186/s13014-020-1465-z
  13. Nag N., Millar J., Davis I.D., Costello S., Duthie J.B., Mark S., et al. Development of indicators to assess quality of care for prostate cancer. Eur. Urol. Focus. 2018; 4(1): 57-63. https://doi.org/10.1016/j.euf.2016.01.016
  14. Lund M., Trads M., Njor S.H., Erichsen R., Andersen B. Quality indicators for screening colonoscopy and colonoscopist performance and the subsequent risk of interval colorectal cancer: a systematic review. JBI Database System Rev. Implement. Rep. 2019; 17(11): 2265-300. https://doi.org/10.11124/JBISRIR-2017-003927
  15. Ramirez P.T. Quality indicators in cervical cancer surgery: a valiant step in the right direction. Int. J. Gynecol. Cancer. 2020; 30(1): 1-2. https://doi.org/10.1136/ijgc-2019-001075
  16. van Rijssen L.B., Koerkamp B.G., Zwart M.J., Bonsing B.A., Bosscha K., van Dam R.M., et al. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. H.P.B. (Oxford). 2017; 19(10): 919-26. https://doi.org/10.1016/j.hpb.2017.06.010
  17. Nguyen M., Ng Ying Kin S., Shum E., Wann A., Tamjid B., Sahu A., et al. Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre. BMC. Palliat. Care. 2020; 19(1): 14. https://doi.org/10.1186/s12904-020-0517-3
  18. van Rijssen L.B., Zwart M.J., van Dieren S., de Rooij T., Bonsing B.A., Bosscha K., et al. Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit. HPB (Oxford) 2018; 20(8): 759-67. https://doi.org/10.1016/j.hpb.2018.02.640
  19. Ortelli L., Spitale A., Mazzucchelli L., Bordoni A. Quality indicators of clinical cancer care for prostate cancer: a population-based study in southern Switzerland. BMC Cancer. 2018; 18(1): 733. https://doi.org/10.1186/s12885-018-4604-2
  20. Baxter M.A., MacDonald G., Malik J., Law A., Dahle-Smith Å., Mmeka W., et al. Testicular cancer: improving outcomes with national quality performance indicators. BMJ Open Qual. 2020; 9(1). https://doi.org/10.1136/bmjoq-2019-000726
  21. Fessele K., Yendro S., Mallory G. Setting the bar: developing quality measures and education programs to define evidence-based, patient-centered, high-quality care. Clin. J. Oncol. Nurs. 2014; 18(Suppl.): 7-11. https://doi.org/10.1188/14.CJON.S2.7-11
  22. Numan R.C., Berge M.T., Burgers J.A., Klomp H.M., van Sandick J.W., Baas P., et al. Pre- and postoperative care for stage I-III NSCLC: Which quality of care indicators are evidence-based? Lung Cancer. 2016; 101: 120-8. https://doi.org/10.1016/j.lungcan.2016.05.022
  23. Min J.K., Cha J.M., Kwak M.S., Yoon J.Y., Jung Y., Shin J.E., et al. Quality indicators and outcome measures of endoscopy in the National Cancer Screening Program. Yonsei Med. J. 2019; 60(11): 1054-60. https://doi.org/10.3349/ymj.2019.60.11.1054
  24. Ponti A., Mano M.P., Tomatis M., Baiocchi D., Barca A., Berti R., et al. Audit system on Quality of breast cancer diagnosis and Treatment (QT): results of quality indicators on screen-detected lesions in Italy, 2011-2012. Epidemiol. Prev. 2015; 39(3 Suppl. 1): 40-7.
  25. ElNaggar A.C., Hade E.M., O’Malley D.M., Liang M.I., Copeland L.J., Fowler J.M., et al. Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center. Gynecol. Oncol. 2018; 151(3): 501-5. https://doi.org/10.1016/j.ygyno.2018.09.014
  26. Fotopoulou C., Concin N., Planchamp F., Morice P., Vergote I., du Bois A., et al. Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update. Int. J. Gynecol. Cancer 2020; 30(4): 436-40. https://doi.org/10.1136/ijgc-2020-001248
  27. Claessen S.J., Francke A.L., Belarbi H.E., Pasman H.R., van der Putten M.J., Deliens L. A new set of quality indicators for palliative care: process and results of the development trajectory. J. Pain Symptom Manage. 2011; 42(2): 169-82. https://doi.org/10.1016/j.jpainsymman.2010.10.267
  28. Lennes I.T., Lynch T.J. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer. Clin. Lung Cancer. 2009; 10(5): 341-6. https://doi.org/10.3816/CLC.2009.n.046
  29. Cibula D., Planchamp F., Fischerova D., Fotopoulou C., Kohler C., Landoni F., et al. European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer. Int. J. Gynecol. Cancer 2020; 30(1): 3-14. https://doi.org/10.1136/ijgc-2019-000878
  30. Cowppli-Bony A., Tretarre B., Marrer E., Defossez G., Daubisse-Marliac L., Coureau G., et al. Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France. PLoS One. 2019; 14(10): e0224275. https://doi.org/10.1371/journal.pone.0224275
  31. Mak K.S., van Bommel A.C., Stowell C., Abrahm J.L., Baker M., Baldotto C.S., et al. Defining a standard set of patient-centred outcomes for lung cancer. Eur. Respir. J. 2016; 48(3): 852-60. https://doi.org/10.1183/13993003.02049-2015
  32. Tighe D., Lewis-Morris T., Freitas A. Machine learning methods applied to audit of surgical outcomes after treatment for cancer of the head and neck. Br. J. Oral Maxillofac. Surg. 2019; 57(8): 771-7. https://doi.org/10.1016/j.bjoms.2019.05.026
  33. Follmann M., Schadendorf D., Kochs C., Buchberger B., Winter A., Wesselmann S. Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification. J. Dtsch Dermatol.Ges. 2014; 12(2): 139-47. https://doi.org/10.1111/ddg.12238
  34. Laronga C., Gray J.E., Siegel E.M., Lee J.H., Fulp W.J., Fletcher M., et al. Florida Initiative for Quality Cancer Care: improvements in breast cancer quality indicators during a 3-year interval. J. Am. Coll. Surg. 2014; 219(4): 638-45e1. https://doi.org/10.1016/j.jamcollsurg.2014.03.063
  35. Jazieh A., Alkaiyat M.O., Ali Y., Hashim M.A., Abdelhafiz N., Al Olayan A. Improving adherence to lung cancer guidelines: a quality improvement project that uses chart review, audit and feedback approach. BMJ Open Qual. 2019; 8(3): e000436. https://doi.org/10.1136/bmjoq-2018-000436
  36. Donabedian A. Evaluating the quality of medical care. Milbank Mem. Fund Q. 1966; 44(3 Suppl.): 166-206.
  37. Albert J.M., Das P. Quality assessment in oncology. Int. J. Radiat. Oncol. Biol. Phys. 2012; 83(3): 773-81. https://doi.org/10.1016/j.ijrobp.2011.12.079
  38. Lewis C.M., Weber R.S., Hanna E.Y. Quality of care in head and neck cancer. Curr. Oncol. Rep. 2011; 13(2): 120-5. https://doi.org/10.1007/s11912-010-0146-8
  39. Francescon S., Fornasier G., Baldo P. Biosimilar oncology drugs in Europe: Regulatory and pharmacovigilance considerations. Oncol. Ther. 2016; 4(2): 173-82. https://doi.org/10.1007/s40487-016-0028-9
  40. Clapes V., Rousseau V., Despas F., Montastruc J.L., Olivier P. Adverse drug reactions involving protein kinase inhibitors: A French Pharmacovigilance Database Study comparing safety in younger and older patients (≥ 75 years) with cancer. Pharmaceut. Med. 2019; 33(1): 21-7. https://doi.org/10.1007/s40290-018-0259-1
  41. Beck N., Hoeijmakers F., Wiegman E.M., Smit H.J.M., Schramel F.M., Steup W.H., et al. Lessons learned from the Dutch Institute for Clinical Auditing: the Dutch model for quality assurance in lung cancer treatment. J. Thorac. Dis. 2018; 10(Suppl. 29): S3472-S85. https://doi.org/10.21037/jtd.2018.04.56
  42. Kueder-Pajares T., Descalzo M.A., Garcia-Doval I., Rios-Buceta L., Moreno-Ramirez D. Evaluation of structure indicators for assessing skin cancer quality of care in dermatology departments. Actas Dermosifiliogr. (Engl. Ed.). 2018; 109(9): 807-12. https://doi.org/10.1016/j.ad.2018.06.004
  43. Mainz J. Developing evidence-based clinical indicators: a state of the art methods primer. Int. J. Qual. Health Care 2003; 15(Suppl. 1): i5-11. https://doi.org/10.1093/intqhc/mzg084
  44. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 2020; 70(1): 7-30. https://doi.org/10.3322/caac.21590
  45. van Bommel A.C., Spronk P.E., Vrancken Peeters M.T., Jager A., Lobbes M., Maduro J.H., et al. Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit. J. Surg. Oncol. 2017; 115(3): 243-9. https://doi.org/10.1002/jso.24516
  46. Oswald N., Hardman J., Kerr A., Bishay E., Steyn R., Rajesh P., et al. Patients want more information after surgery: a prospective audit of satisfaction with perioperative information in lung cancer surgery. J. Cardiothorac. Surg. 2018; 13(1): 18. https://doi.org/10.1186/s13019-018-0707-8
  47. Tian H., Yang W., Hu Y., Liu Z., Chen L., Lei L., et al. Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China. EClinicalMedicine. 2020; 20: 100312. https://doi.org/10.1016/j.eclinm.2020.100312
  48. Okuyama A., Barclay M., Chen C., Higashi T. Impact of loss-to-follow-up on cancer survival estimates for small populations: a simulation study using Hospital-Based Cancer Registries in Japan. BMJ Open. 2020; 10(1): e033510. https://doi.org/10.1136/bmjopen-2019-033510
  49. Palazzo S., Mangone L. Regional Cancer Registries as observational points for clinical pathways in oncological networks. Recenti Prog. Med. 2017; 108(6): 259-60. https://doi.org/10.1701/2715.27711 (in Italian)
  50. Thompson T.D., Pollack L.A., Johnson C.J., Wu X.C., Rees J.R., Hsieh M.C., et al. Breast and colorectal cancer recurrence and progression captured by five U.S. population-based registries: Findings from National Program of Cancer Registries patient-centered outcome research. Cancer Epidemiol. 2020; 64: 101653. https://doi.org/10.1016/j.canep.2019.101653
  51. Dearmon B.J. International Association of Cancer Registries Conference Review 2018: Arequipa, Peru. J. Registry Manag. 2018; 45(4): 177-80.
  52. Zachary I., Boren S.A., Simoes E., Jackson-Thompson J., Davis J.W., Hicks L. Information management in cancer registries: Evaluating the needs for cancer data collection and cancer research. Online J. Public Health Inform. 2015; 7(2): e213. https://doi.org/10.5210/ojphi.v7i2.5664
  53. Hoeijmakers F., Beck N., Wouters M., Prins H.A., Steup W.H. National quality registries: how to improve the quality of data? J. Thorac. Dis. 2018; 10(Suppl. 29): S3490-S9. https://doi.org/10.21037/jtd.2018.04.146
  54. Nartey Y., Stewart I., Khakwani A., Beattie V., Wilcock A., Woolhouse I., et al. Is the English Cancer Patient Experience Survey representative? A comparative analysis with the National Lung Cancer Audit. Lung Cancer 2020; 140: 27-34. https://doi.org/10.1016/j.lungcan.2019.11.023
  55. Kalyani C.V., Sharma S.K., Kusum K., Lijumol K.J. Healthcare-related quality of life and lived existential experien-ces among young adults diagnosed with cancer: A mixed-method study. Indian J. Palliat. Care 2020; 26(1): 19-23. https://doi.org/10.4103/IJPC.IJPC_207_18
  56. Bronserud M.M., Iachina M., Green A., Groenvold M., Jakobsen E. Patient reported outcome data as performance indicators in surgically treated lung cancer patients. Lung Cancer. 2019; 130: 143-8. https://doi.org/10.1016/j.lungcan.2019.02.010
  57. Rowen D., Brazier J., Young T., Gaugris S., Craig B.M., King M.T., et al. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health 2011; 14(5): 721-31. https://doi.org/10.1016/j.jval.2011.01.004
  58. Shine R., Bui A., Burgess A. Quality indicators in colonoscopy: an evolving paradigm. ANZ J. Surg. 2020; 90(3): 215-21. https://doi.org/10.1111/ans.15775
  59. Piven D.V., Kitsul I.S., Ivanov I.V. Legal regulation of internal control of the quality and safety of medical activity. Menedzher zdravookhraneniya. 2016; (5): 38–46. (in Russian)
  60. Henson L.A., Edmonds P., Johnston A., Johnson H.E., Ng Yin Ling C., Sklavounos A., et al. Population-based quality indicators for end-of-life cancer care: A systematic review. JAMA Oncol. 2019; 6(1): 142-50. https://doi.org/10.1001/jamaoncol.2019.3388

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Andreev D.A., Zavyalov A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ:  ПИ № ФС77-50668 от 13.07.2012 г.